BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://www.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20171128T090000
DTEND;TZID=Europe/London:20171129T170000
DTSTAMP:20260316T000033
CREATED:20171016T115132Z
LAST-MODIFIED:20171016T115132Z
UID:17719-1511859600-1511974800@www.medilinkmidlands.com
SUMMARY:BioFIT Conference
DESCRIPTION:BioFIT is the leading partnering event in Europe for technology transfer\, academia-industry collaborations\, early-stage innovation and seed investment in the field of Life Sciences. With more than 1\,200 international leading actors from 35+ countries\, the event gathers big pharma\, emerging and small biotech companies\, pre-seed/seed/Series A investors\, as well as professionals from tech transfer\, academia and research institutions. \nThe Conference Programme at a glance \nNew players involved in innovation in the health sector\nBig data and health IT companies provide key expertise to potentially increase efficiency in the discovery\, preclinical and clinical stages of development. What will be their position and involvement in the therapeutic innovation chain: Will they participate or lead? Examples of collaborations between biotech\, pharma and academic research will be highlighted. However\, these new players don’t only originate from the big data sector\, they also come from various areas such as animal health or e-health. \nNurturing and licensing early-stage assets\nEarly stage assets evolve in an ecosystem in which TTOs\, scientists and entrepreneurs are closely connected. This subject will focus on assessing opportunities in licensing early-stage projects\, discussing the monitoring role of TTOs and exploring the scientists’ commitment. It aims to underline the difficulties for maturing early-stage assets. How can we transform science into business more frequently and efficiently? \nBioentrepreneurs’ challenges at pre-seed\, seed and Series A stages\nThe right mindset\, a solid presentation and business model are not the sole requirements that bioentrepreneurs must fulfill at pre-seed\, seed and Series A stages. What are the expectations of project maturity from seed investors in 2018? How often are new types of early-stage investors involved in financing rounds (including philanthropic and specialised ventures)? How does the angles/seed investors relationship work? Are there increasing interactions and partnerships between pharma and VCs at these initial stages? \nRegister Now for BioFit 2017\nMedilink members can receive 25% off booking fees. There are also sponsorship and exhibition opportunities available. To find out more or register your place\, please click here.
URL:https://www.medilinkmidlands.com/event/biofit-conference/
LOCATION:Strasbourg Convention Centre\, Palais de la Musique et des Congrés\, Place de Bordeaux\, Strasbourg\, 67082\, France
END:VEVENT
END:VCALENDAR